Bidya Dhar Sahu

2.5k total citations
58 papers, 2.1k citations indexed

About

Bidya Dhar Sahu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Complementary and alternative medicine. According to data from OpenAlex, Bidya Dhar Sahu has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Pathology and Forensic Medicine and 8 papers in Complementary and alternative medicine. Recurrent topics in Bidya Dhar Sahu's work include Inflammasome and immune disorders (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Natural product bioactivities and synthesis (5 papers). Bidya Dhar Sahu is often cited by papers focused on Inflammasome and immune disorders (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Natural product bioactivities and synthesis (5 papers). Bidya Dhar Sahu collaborates with scholars based in India, United States and Belgium. Bidya Dhar Sahu's co-authors include Ramakrishna Sistla, Madhusudana Kuncha, Jerald Mahesh Kumar, Meghana Koneru, Shyam Sunder Rachamalla, Madhav Nilakanth Mugale, Uday Kumar Putcha, Roshan M. Borkar, R. Srinivas and Upadhyayula Suryanarayana Murty and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Bidya Dhar Sahu

55 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bidya Dhar Sahu India 26 745 462 291 248 215 58 2.1k
Mi Jeong Sung South Korea 29 1.2k 1.6× 472 1.0× 187 0.6× 147 0.6× 165 0.8× 70 2.6k
Dharamvir Singh Arya India 33 910 1.2× 551 1.2× 300 1.0× 304 1.2× 302 1.4× 92 2.7k
Jagriti Bhatia India 33 942 1.3× 458 1.0× 415 1.4× 315 1.3× 361 1.7× 93 3.0k
Ghada M. Suddеk Egypt 28 546 0.7× 238 0.5× 268 0.9× 168 0.7× 185 0.9× 77 1.8k
Xufeng Tao China 29 1.3k 1.7× 253 0.5× 267 0.9× 121 0.5× 202 0.9× 66 2.7k
Sana Nafees India 23 534 0.7× 415 0.9× 466 1.6× 188 0.8× 217 1.0× 47 1.7k
Xiaofeng Yu China 30 1.5k 2.1× 257 0.6× 334 1.1× 360 1.5× 190 0.9× 124 3.0k
Robert Domitrović Croatia 28 748 1.0× 479 1.0× 686 2.4× 298 1.2× 370 1.7× 54 2.5k
Heqing Huang China 31 1.3k 1.7× 195 0.4× 311 1.1× 482 1.9× 242 1.1× 95 2.7k
Phiwayinkosi V. Dludla South Africa 33 1.1k 1.5× 285 0.6× 258 0.9× 182 0.7× 278 1.3× 143 3.4k

Countries citing papers authored by Bidya Dhar Sahu

Since Specialization
Citations

This map shows the geographic impact of Bidya Dhar Sahu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bidya Dhar Sahu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bidya Dhar Sahu more than expected).

Fields of papers citing papers by Bidya Dhar Sahu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bidya Dhar Sahu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bidya Dhar Sahu. The network helps show where Bidya Dhar Sahu may publish in the future.

Co-authorship network of co-authors of Bidya Dhar Sahu

This figure shows the co-authorship network connecting the top 25 collaborators of Bidya Dhar Sahu. A scholar is included among the top collaborators of Bidya Dhar Sahu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bidya Dhar Sahu. Bidya Dhar Sahu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mishra, A. P., et al.. (2025). Fabrication, Characterization, and Clinical Assessment of Ultrathin Skin-Conformable Tattoo Electrodes for ECG Monitoring. ACS Applied Electronic Materials. 7(4). 1611–1621. 4 indexed citations
2.
Rajput, Ali H., et al.. (2025). Phytochemicals Targeting Inflammatory Pathways in Alcohol-Induced Liver Disease: A Mechanistic Review. Pharmaceuticals. 18(5). 710–710.
3.
Sahu, Bidya Dhar, et al.. (2025). Deciphering the Emerging Signaling Pathways That Interplay Between Chronic Kidney Disease and Heart: Therapeutic Challenges and Opportunities. Journal of Biochemical and Molecular Toxicology. 39(8). e70409–e70409.
4.
Sahu, Bidya Dhar, et al.. (2024). Unraveling the role of RIPKs in diabetic kidney disease and its therapeutic perspectives. Biochemical Pharmacology. 231. 116642–116642. 1 indexed citations
6.
Mugale, Madhav Nilakanth, et al.. (2024). Nuciferine inhibits TLR4/NF-κB/MAPK signaling axis and alleviates adjuvant-induced arthritis in rats. European Journal of Pharmacology. 982. 176940–176940. 5 indexed citations
7.
Bonam, Srinivasa Reddy, et al.. (2024). Role of NLRP3 inflammasome in nanoparticle adjuvant-mediated immune response. Biomaterials Science. 13(9). 2164–2178. 6 indexed citations
8.
Mugale, Madhav Nilakanth, et al.. (2024). Biochanin A mitigates ulcerative colitis and intestinal inflammation in mice by inhibiting MAPK/NF‐kB (p65) axis. Journal of Biochemical and Molecular Toxicology. 38(6). e23738–e23738. 4 indexed citations
10.
11.
Garg, Vikas, et al.. (2023). Carvacrol and its effect on cardiovascular diseases: From molecular mechanism to pharmacological modulation. Food Bioscience. 57. 103444–103444. 5 indexed citations
12.
Sahu, Bidya Dhar, et al.. (2023). Role of lncRNAs in hepatocellular carcinoma. Life Sciences. 325. 121751–121751. 28 indexed citations
13.
Chaudhari, Vishal Sharad, et al.. (2022). Nootkatone Essential Oil-Encapsulated Lipid Nanoparticles Interaction with Rat Cardiomyoblast (H9c2) Cells. 8(1). 14–23. 2 indexed citations
14.
Sahu, Bidya Dhar, et al.. (2022). Biological Activities, Pharmacokinetics and Toxicity of Nootkatone: A Review. Mini-Reviews in Medicinal Chemistry. 22(17). 2244–2259. 12 indexed citations
15.
Kundu, Sourav, et al.. (2022). Nuciferine alleviates intestinal inflammation by inhibiting MAPK/NF-κB and NLRP3/Caspase 1 pathways in vivo and in vitro. International Immunopharmacology. 115. 109613–109613. 24 indexed citations
16.
Kundu, Sourav, et al.. (2022). Natural coumarins: Preclinical evidence-based potential candidates to alleviate diabetic nephropathy. Phytomedicine Plus. 2(4). 100379–100379. 16 indexed citations
17.
Ahmed, Sahabuddin, Samir Ranjan Panda, Mohit Kwatra, Bidya Dhar Sahu, & V.G.M. Naidu. (2021). Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson’s Disease. ACS Chemical Neuroscience. 13(1). 53–68. 26 indexed citations
18.
Ghosh, Aparajita, et al.. (2020). Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches. European Journal of Pharmacology. 885. 173503–173503. 52 indexed citations
19.
Sahu, Bidya Dhar, et al.. (2014). Chromium-induced nephrotoxicity and ameliorative effect of carvedilol in rats: Involvement of oxidative stress, apoptosis and inflammation. Chemico-Biological Interactions. 223. 69–79. 64 indexed citations
20.
Sahu, Bidya Dhar, Meghana Koneru, Jerald Mahesh Kumar, et al.. (2014). Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: Possible involvement of mitochondrial dysfunction and apoptosis. Life Sciences. 107(1-2). 59–67. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026